RadConnect Communication Application
RadConnect
1 other identifier
observational
79
1 country
1
Brief Summary
The aim is to evaluate the impact of an innovative asynchronous communication application on the number of calls from technologists to radiologists. Even though it is paramount that radiologists be accessible and available to other healthcare workers in the enterprise, frequent interruptions have negative impact on productivity and well-being. A novel communication app was developed that streamlines communication between technologists and radiologists: RadConnect.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2022
CompletedFirst Posted
Study publicly available on registry
September 14, 2022
CompletedStudy Start
First participant enrolled
September 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 13, 2023
CompletedJuly 21, 2023
July 1, 2023
10 months
September 8, 2022
July 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Test the hypothesis that adoption of RadConnect leads to reduction of phone calls to radiologists.
* P1 = Mean number of calls per working day during regular working hours between Sending Extensions and Receiving Extensions in Before Phase * P2 = Mean number of calls per working day during regular working hours between Sending Extensions and Receiving Extensions in After Phase The primary endpoint will be obtained by testing the hypothesis that P1 \> P2 using Wilcoxon's one-tailed test with significance level P \< 0.05.
Numbers are continously measured during each shift of the subjects over a period of 40 consecutive working days during the before (phase 1) and 40 consecutive working days during the after phase (phase 2) of this study.
Secondary Outcomes (3)
Compare experiences and attitudes of technicians and radiologists towards RadConnect versus phone calls.
Continously measured during each shift of the subjects over a period of 40 consecutive working days during the before (phase 1) and 40 consecutive working days during the after phase(phase 2) of this study.
Measure the characteristics of technician questions raised over phone and through RadConnect.
Continously measured during each shift of the subjects over a period of 40 consecutive working days during the before phase (phase 1) and 40 consecutive working days during the after phase (phase 2) of this study.
Consolidated opinion usability and experience of RadConnect in itself and in comparison to alternative communication methods.
1 hour, after completion of the after phase (phase 2 of this study)
Interventions
The study will be performed in a clinical setting at the department of radiology of LUMC, meaning that we aim to test the hypothesis that ("RadConnect") can reduce the number of phone calls from a select set of extension used by technologists (the "Sending Extensions") to another select set of extensions manned by radiologists ("Receiving Extensions").
Eligibility Criteria
Subjects are not patients, but radiologists, technologist, doctor assistants and physician assistants employeed by LUMC. That drive the radiological workflow and frequently raise and answer questions related to the image acquisition.
You may qualify if:
- Individuals that are employed by LUMC
- Individuals that are radiologists, radiology fellows, radiology residents, radiology technologists, doctor assistants, physician assistants or other support personnel in the Department of Radiology that raise managing image acquisition related questions.
- Individuals that consent to participating in the study.
- Individuals scheduled to work at locations at Sending Extensions, Receiving Extensions and Control Extensions.
You may not qualify if:
- Individuals not able to understand or not willing to sign the informed consent form.
- Individuals that indicate that they do no comprehend RadConnect and/or its intended use after two educational sessions.
- Individuals not able to not willing to comply with the intended use of RadConnect.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Leiden University Medical Center (LUMC)
Leiden, 2333 ZA, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hildo Lamb, Prof. Dr.
Leiden University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2022
First Posted
September 14, 2022
Study Start
September 29, 2022
Primary Completion
July 13, 2023
Study Completion
July 13, 2023
Last Updated
July 21, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share